Measuring Response to Adjunctive Therapy Among Individuals with Major Depressive Disorder
Felicia Forma,1 Joshua N Liberman,2 Pinyao Rui,2 Emily Wiggins,2 Charles Ruetsch2 1Health Economics & Real-World Evidence, Formerly Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USA; 2Health Analytics, LLC, Columbia, MD, USACorrespondence: Joshua N Liberman, Tel...
Main Authors: | Forma F, Liberman JN, Rui P, Wiggins E, Ruetsch C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-10-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/measuring-response-to-adjunctive-therapy-among-individuals-with-major--peer-reviewed-fulltext-article-NDT |
Similar Items
-
Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial
by: Atefeh Zandifar, et al.
Published: (2021-01-01) -
Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder
by: Yan T, et al.
Published: (2020-02-01) -
Validity and diagnostic accuracy of the Luganda version of the 9-item and 2-item Patient Health Questionnaire for detecting major depressive disorder in rural Uganda
by: J. E. M. Nakku, et al.
Published: (2016-01-01) -
The Association of Depressive Symptoms With Plasma C-Reactive Protein in Patients With Major Depressive Disorder Under Treatment
by: Azher Nema Mohammed Al-Agam, et al.
Published: (2021-12-01) -
Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder
by: X.J. Wen, et al.
Published: (2014-07-01)